Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06214468 · ClinicalTrials.gov registry record · Phase 1
Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity
A Phase 1 study, sponsored by University of South Alabama.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT06214468: Completed Phase 1 study, sponsored by University of South Alabama.
NCT06214468 is a Phase 1 study that has completed, run by University of South Alabama. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06214468, a Phase 1 study, has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
Over-the-counter drugs like acetaminophen (e.g., Tylenol®) can be detrimental. In space, astronauts who have pain and constant discomfort use acetaminophen extensively. Investigators are studying the effects of acetaminophen under space-like conditions since acetaminophen might affect astronauts' health. Investigators also wish to see whether a dietary supplement can reduce some negative effects of acetaminophen. It is believed that acetaminophen promotes the productions of chemicals in the body that could be toxic. In this study, measurements of these chemicals in urine after ingestion of 1 tablet of acetaminophen and compare these measurements to when acetaminophen is taken at the same time as a dietary supplement. This study will also explore whether these products are more abundant when blood is placed under conditions that mimic space. Therefore, this study will collect blood from a few volunteers who took acetaminophen, and acetaminophen with the dietary supplement.
Interventions
- DRUG Acetaminophen
- COMBINATION_PRODUCT Acetaminophen and Nicotinamide Riboside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2025-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06214468
The ClinicalTrials.gov registry entry for NCT06214468 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT06214468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06214468 about?
NCT06214468 is a clinical study titled "Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity". Over-the-counter drugs like acetaminophen (e.g., Tylenol®) can be detrimental. In space, astronauts who have pain and constant discomfort use acetaminophen extensively. Investigators are studying the effects of acetaminophen under space-like conditions since acetaminophen might affect astronauts' he...
What is the current status of trial NCT06214468?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2024-01-15. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT06214468?
The interventions under investigation include: Acetaminophen (DRUG), Acetaminophen and Nicotinamide Riboside (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06214468?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.